Xtant Medical Holdings (XTNT) Research & Development (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Research & Development of $634000.0 for Q3 2025, down 9.56% year-over-year from $701000.0 in Q3 2024, and down 94.54% quarter-over-quarter from $11.6 million in Q2 2025.
Xtant Medical Holdings (XTNT) Research & Development (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Research & Development for 16 consecutive years, with $634000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Research & Development fell 9.56% year-over-year to $634000.0; the TTM figure through Sep 2025 stood at -$11.7 million (down 146.06% YoY), while the FY2024 annual figure was $2.4 million, down 93.8% from the prior year.
- Research & Development retreated to $634000.0 in Q3 2025 per XTNT's latest filing, from $11.6 million in the prior quarter.
- Across five years, Research & Development topped out at $21.8 million in Q4 2022 and bottomed at -$35.1 million in Q4 2024.
- Historically, Research & Development has averaged $3.9 million across 5 years, with a median of $5.2 million in 2022.
- Annual changes were most pronounced in 2022 — Research & Development soared 14358.28% — and 2024, when it plunged 403.39%.
- Xtant Medical Holdings' Research & Development stood at $151000.0 in 2021, then jumped by 14358.28% to $21.8 million in 2022, then tumbled by 46.94% to $11.6 million in 2023, then slumped by 403.39% to -$35.1 million in 2024, then surged by 101.8% to $634000.0 in 2025.
- Business Quant data shows XTNT's Research & Development at $634000.0 in Q3 2025, $11.6 million in Q2 2025, and $11.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Xtant Medical Holdings | 46.73 Mn | 29.13 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 11.62 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | -35.15 Mn |
| Sep 30, 2024 | 701,000.00 |
| Jun 30, 2024 | 636,000.00 |
| Mar 31, 2024 | 12.46 Mn |
| Dec 31, 2023 | 11.58 Mn |
| Sep 30, 2023 | 490,000.00 |
| Jun 30, 2023 | 8.72 Mn |
| Mar 31, 2023 | 7.05 Mn |
| Dec 31, 2022 | 21.83 Mn |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 5.21 Mn |
| Dec 31, 2021 | 151,000.00 |
| Sep 30, 2021 | 5.27 Mn |
| Jun 30, 2021 | 5.59 Mn |
| Mar 31, 2021 | 4.86 Mn |
| Dec 31, 2020 | 128,000.00 |